Insulong

Insulong: Intermediate-acting insulins from Croatia

Insulong is a pharmaceutical product belonging to the group of intermediate-acting insulins. It is produced in Croatia by the company Pliva. The international name of this drug is Insulin-SrD. Insulong is an injection suspension containing 40 U/ml insulin.

Insulin is an important hormone that regulates blood glucose (sugar) levels. In people with diabetes, glucose levels may be elevated due to a lack of or problems with insulin. Injecting insulin helps normalize glucose levels in the body.

Insulong has an intermediate duration of action, which means that its effect on blood glucose levels lasts for a certain period of time. This distinguishes it from other types of insulin, such as rapid-acting or long-acting. The duration of action of insulin depends on the individual patient and may be individual.

Insulong is manufactured by Pliva in Croatia. Pliva is a well-known manufacturer of pharmaceuticals and has a good reputation in the industry. Insulong is also known under various synonyms, such as B-Insulin Berlin-Chemie, Berlinsulin N Basal U-40, Berlinsulin N Basal pen and others.

The dosage form of Insulong is an injection suspension containing 40 U/ml insulin. To use the drug, you must follow the instructions provided by your doctor or indicated on the package.

It is important to note that this article provides general information about Insulong. If you have specific questions or require medical advice, it is recommended that you consult a qualified physician or pharmacist for more detailed information about this drug and its use.